Innovative Life Sciences Advisory Solutions
Strategically navigating Healthcare challenges for sustainable growth
Pharma Research & Development
Bridge new and old knowledge and therapies and add an ethical lens
Understand ethical issues and requirements, assess your business and embed strategic ethical frameworks and innovation
Grow or transform your business by creating an ecosystem of carefully selected and ethical partners for your strategic goals
Ethical Design & Innovation in MedTech and Healthcare
Strategic Partnerships
Innovating in Healthcare and Pharma through Healthy Strategic Partnerships
IGEA Healthcare is a life sciences advisory firm dedicated to fostering responsible innovation through integrated and ethical solutions in data analytics, medical products and services in areas such as Neuroscience, Immunology or Oncology in MedTech, Healthcare and Pharma.
We help you find, assess (through both a commercial and ethical lens) and integrate the right business partners and vendors in line with your organisation goals, standards and culture in areas like:
Data and Digital Solutions across Commercial, R&D and Business Development
To be able to make more informed, strategic and faster decisions, streamline and integrate various software and apps, whilst making sure there are no ethical issues and risks at play.
(In and Out) Licensing Deals
Decide which are the most relevant product candidates and target firms for your key TAs and for your overall business goals and how does their profile fit with your own organisation's structure, culture, ethics, management and strategy.
Medical and Marketing Omnichannel Set-up, Delivery and Analytics
To completely redefine HCP engagement ethically (e.g. through proper consent management, ethical content, channel integrity, data ethics) to craft relevant customer journeys, to measure ROI, Brand Health and more.
It is reassuring that when compared to other industries, strategic partnerships in Pharma seem more successful according to industry experts, with a 50 - 60% success rate, compared to just 20% - 40% in other areas. But the higher the cultural differences and the more divergent the ways of doing business, the higher the chances of failure are. That is why before any type of important deal or partnership, an organisation should undertake an in-depth strategic vendor and/or target assessment - to assess fit from various perspectives and mitigate risks, ultimately ensuring those vendors become long term synergistic partners, not foes.
Innovating in Healthcare through Strategic Partnerships
IGEA Healthcare is a life sciences advisory firm dedicated to fostering innovation in Switzerland, the UK and Italy, through integrated innovative and ethical healthcare data and analytics solutions in areas such as Neuroscience, Oncology, Immunology in Pharma, Food and MedTech sectors.
We help you find, assess and integrate the right business partners and vendors in line with your organisation strategic goals and constraints in areas like:
(In and Out) Licensing Deals - decide which are the most relevant candidates and targets for your key TAs and your overall business goals and how does the owner company's profile fit with your own organisation's structure, culture, management and strategy
Data and Digital Solutions across Commercial, R&D and Business Development - to be able to make more informed, strategic and faster decisions, streamline and integrate various software and apps
Medical and Marketing Omnichannel Set-up, Delivery and Analytics - to completely redefine HCP engagement
Unlocking Value in Commercial Operations
We drive strategic innovation in Commercial Operations in areas such as Medical and Marketing Omnichannel Strategy, Delivery and Analytics
Reporting and Analytics
We help you achieve competitive advantage through in-built innovation value chains and innovation processes in order to create and capture value across all necessary channels and Commercial business functions (Sales, Distribution, Marketing and Medical Affairs).
We appreciate organisations can be unique in their business structure and design, size, culture and strategy. Yet, an integrated and data driven approach in all these functions which manage the commercialised portfolio is more than ever paramount for brokering knowledge, fostering (sustainable) innovation, unlocking and creating value through synergies between functions and ensuring overall business viability and growth in an ever changing volatile external environment.
Commercial Excellence and Integration
From Exploration phase to the Business Case Development and Approval and through Discovery and Preparation, Recruitment, Planning, Onboarding and Training/Knowledge Transfer - we can support and manage all the stages of designing and building amazing Reporting and Analytics teams.
We can also help with choosing the best metrics for Omnichannel Reporting, Brand Analytics, Customer Interaction Reporting, Market Access Reporting and overall Insights & Analytics.
Lastly, depending on your business size and complexity, we can help you choose and assess key vendors for external data, software and analytics and best tailor their services to your specific organisational needs.
Target Audience
Pharma, Biotech and MedTech companies need not only patient-centric approaches but also audience-centric approaches, where knowing your key HCP segments (including their beliefs, behaviours and channel preferences) is key to optimising the engagement and ultimately to business success.
We help clients design and implement their Omnichannel strategy, chose the best tools and platforms for analysing and optimising Omnichannel campaigns, strategically assess different Omnichannel related software and delivery vendors as well as assess ethical issues related to Marketing and Medical Omnichannel campaigns and embed relevant governance frameworks.
Pharma companies that have implemented an effective Omnichannel strategy and are delivering Omnichannel campaigns have noticed an increase in sale revenue of up to 15% (Aktana Research, 2022). On the other hand, using advanced Analytics and AI in Omnichannel strategy can lead to a 15-20% increase in ROI (return on investment) and up to 20% revenue growth.
Unlocking Value in Healthcare and MedTech through Ethical Design and Innovation
We help with ethical assessment of existing products and services, build and embed new design frameworks that fit with both social responsibility and regulatory requirements
Ethical Training and Development
External data is now being used for the initial development of products, services and entire digital infrastructures, vast amounts of internal data is generated, stored, used and reused by MedTech and Healthcare providers and researchers - and this comes with ever increasing cost, legal and above all, ethical implications.
Apart from data itself, the various intended and non-intended uses of a device or software have to be considered, to mitigate any potential harm - now and in the longer term (as far as it is reasonably possible to predict).
MedTech - Ethical Data, Product and Service Assessment
We run internal workshops and seminars focussed on ethical issues and risks in your business - related to AI technologies or other ethically charged aspects.
When it comes to AI literacy courses, sometimes ethical implications are not fully covered and sometimes not fully understood.
We do our best to ensure your people and decision makers get a good grasp of these really important but not always easily detectable or well enough understood issues.
Ethical Design and Innovation Frameworks
We help you build and embed ethical design frameworks for your products or services - starting from analysing your desired business goals, your regulatory and cost constraints, overall best practices and recommendations in your market segment.
We also help with overall ethical innovation strategy - we help you design a new innovation business model and embed strategic ethical practices.
Contextual integrity, data protection and privacy by design are not just buzz words but increasing business imperatives.
Ethical design builds trust with physicians, patients, regulators, insurers and your overall ecosystem and unlocks value in the medium to long term.
Ethics and Responsible Innovation pay off in the long run - a Deloitte study found that 76% of healthcare consumers are more likely to trust companies that are transparent about how they use data and make decisions; also ethical design and transparency in clinical trials and post-market surveillance can lead to quicker approvals and fewer recalls, saving money long term and building a good reputation.
Unlocking Value in Commercial Operations
We drive strategic innovation in Commercial Operations in areas such as Medical and Marketing Omnichannel Strategy, Delivery and Analytics
Reporting and Analytics
We help you achieve competitive advantage through in-built innovation value chains and innovation processes in order to create and capture value across all necessary channels and Commercial business functions (Sales, Distribution, Marketing and Medical Affairs).
We appreciate organisations can be unique in their business structure and design, size, culture and strategy. Yet, an integrated and data driven approach in all these functions which manage the commercialised portfolio is more than ever paramount for brokering knowledge, fostering (sustainable) innovation, unlocking and creating value through synergies between functions and ensuring overall business viability and growth in an ever changing volatile external environment.
Commercial Excellence and Integration
From Exploration phase to the Business Case Development and Approval and through Discovery and Preparation, Recruitment, Planning, Onboarding and Training/Knowledge Transfer - we can support and manage all the stages of designing and building amazing Reporting and Analytics teams - regardless of whether you're looking to: *build in-house capabilities or *adapt an external vendor's services or *switch from one vendor to another and ensure proper knowledge transfer (KT) and that your know-how, data and other IP remain in-house.
We can also help with choosing the best metrics for Omnichannel Reporting, Brand Analytics, Customer Interaction Reporting, Market Access Reporting and overall Insights & Analytics.
Lastly, depending on your business size and complexity, we can help you choose and assess external data, analytics and software vendors and best tailor their services to your specific organisation and needs.
Target Audience
Pharma, Biotech and MedTech companies need not only patient-centric approaches but also audience-centric approaches, where knowing your key HCP segments (including their beliefs, behaviours and channel preferences) is key to optimising the engagement and ultimately to business success.
We help clients design and implement their Omnichannel strategy, chose the best tools and platforms for analysing and optimising Omnichannel campaigns, strategically assess different Omnichannel related software and delivery vendors as well as assess ethical issues related to Marketing and Medical Omnichannel campaigns and embed relevant governance frameworks.
Pharma companies that have implemented an effective Omnichannel strategy and are delivering Omnichannel campaigns have noticed an increase in sale revenue of up to 15% (Aktana Research, 2022). On the other hand, using advanced Analytics and AI in Omnichannel strategy can lead to a 15-20% increase in ROI (return on investment) and up to 20% revenue growth.
Pharma R&D - Responsible Solutions for the Future
Expert guidance to drive responsible innovation and sustainable business growth for clients, while integrating old and new knowledge and solutions
Ethical R&D Business Innovation
We assist in navigating research challenges from a management perspective to help you build organisational capacity for innovation in an ethical and long term sustainable way; ensure you both capture and create value in your R&D function through a variety of tools and without compromising on quality or ethics.
Product Pipeline & Portfolio Analysis and Management
A company may have stellar scientific descriptions of its products and candidates, but how about their past, present and future financial performance? how about their ethical profile - from the way clinical trials are conducted to how data is captured, used, stored etc. and to any health and wellbeing risks for patients? how about specific regulatory compliance (e.g. MDR, EU AI Act)?how do they compare to similar drugs/devices from competitors?
Our advisory services include insights into bioethics and data & AI ethics ensuring both responsible and effective R&D innovation practices, aware of current socioeconomic, legal and ethical paradigms.
We also work with organisations to design and implement relevant biodata governance frameworks and ethical R&D project management frameworks.
Bioethics and Biodata Governance
In a market where only about 10% of drug candidates in development successfully navigate through all phases of clinical trials and regulatory approval to reach the commercialisation phase (IQVIA, 2024), we work with businesses to help them create capacity for innovation, improve ethical decision making and improve the odds of long term sustainable success.
Research & Development Solutions
We provide expert guidance in Life Sciences to drive responsible innovation and business growth for clients, while integrating old and new knowledge and solutions
R&D Business Innovation
Our team assists in navigating research challenges from a management perspective to help you build organisational capacity for innovation and ensure you both capture and create value in your R&D function through a variety of tools
Product Pipeline & Portfolio Analysis and Management
A company may have stellar scientific descriptions of its products and candidates, but how about their past, present and future financial performance? how do they compare to similar drugs from competitors? are there any inherent market, business or health risk and if yes, how could they be mitigated?
Our advisory services include insights into bioethics and data & AI ethics ensuring both responsible and effective R&D innovation practices, aware of current socioeconomic, business and ethical paradigms
We also work with organisations to design and implement relevant biodata governance frameworks and R&D project management frameworks
Bioethics and Biodata Governance
In a market where only about 10% of drug candidates in development successfully navigate through all phases of clinical trials and regulatory approval to reach the commercialisation phase (source: IQVIA, 2024), we work with businesses to help them create capacity for innovation, improve decision making and improve the odds of long term sustainable success.
IGEA Healthcare
Strategic Advisory for Life Sciences
Switzerland, UK, Italy
contact@igeahealthcare.com
© 2025. All rights reserved.
